• Profile
Close

Clinical significance of hepatic steatosis according to coronary plaque morphology: Assessment using controlled attenuation parameter

Journal of Gastroenterology Oct 31, 2018

Park HE, et al. - A retrospective cohort study was conducted to assess the relationship between controlled attenuation parameter (CAP)-defined nonalcoholic fatty liver disease (NAFLD) and the presence of any type of coronary plaques and various plaque compositions. The study sample consisted of seemingly healthy patients who had liver Fibroscan and coronary computed tomography at the time of health screening exams. It was noted that CAP ≥ 222 dB/m was not significant in calcified plaques, though it was significantly related to non-calcified plaque. An independent association was found between CAP-defined NAFLD and coronary plaques, particularly non-calcified plaques. Specific consideration ought to be given to the patients with NAFLD for primary prevention, given the correlation between NAFLD and non-calcified plaques.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay